Related references
Note: Only part of the references are listed.Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study
Pascal F. Durrenberger et al.
ACTA NEUROPATHOLOGICA (2012)
Amyloid Generation and Dysfunctional Immunoproteasome Activation with Disease Progression in Animal Model of Familial Alzheimer's Disease
Ester Aso et al.
BRAIN PATHOLOGY (2012)
Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model
Willem Kamphuis et al.
GLIA (2012)
Stability of endogenous reference genes in postmortem human brains for normalization of quantitative real-time PCR data: comprehensive evaluation using geNorm, NormFinder, and BestKeeper
Qi Wang et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2012)
TLR2 Is a Primary Receptor for Alzheimer's Amyloid β Peptide To Trigger Neuroinflammatory Activation
Shirong Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Cognitive and Behavioral Consequences of Impaired Immunoregulation in Aging
Angela W. Corona et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Brent Cameron et al.
JOURNAL OF NEUROSCIENCE (2012)
Mice completely lacking immunoproteasomes show major changes in antigen presentation
Eleanor Z. Kincaid et al.
NATURE IMMUNOLOGY (2012)
GFAPδ Expression in Glia of the Developmental and Adolescent Mouse Brain
Carlyn Mamber et al.
PLOS ONE (2012)
Immunoproteasome expression is induced in mesial temporal lobe epilepsy
Michele Mishto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The Immunoproteasomes Regulate LPS-Induced TRIF/TRAM Signaling Pathway in Murine Macrophages
Julia Reis et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2011)
Endoplasmic reticulum stress activates autophagy but not the proteasome in neuronal cells: implications for Alzheimer's disease
D. A. T. Nijholt et al.
CELL DEATH AND DIFFERENTIATION (2011)
The immunoproteasome in steatohepatitis: Its role in Mallory-Denk body formation
B. A. French et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
TLR2 Hypersensitivity of Astrocytes as Functional Consequence of Previous Inflammatory Episodes
Anja Henn et al.
JOURNAL OF IMMUNOLOGY (2011)
Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome
Zhi-Feng Luo et al.
LIFE SCIENCES (2011)
Recent advances in (patho)physiology of astroglia
Alexei Verkhratsky et al.
ACTA PHARMACOLOGICA SINICA (2010)
Persistent Hijacking of Brain Proteasomes in HIV-Associated Dementia
Trung P. Nguyen et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes
Andrew M. Pickering et al.
BIOCHEMICAL JOURNAL (2010)
Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress
Ulrike Seifert et al.
CELL (2010)
Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis
Nicole Schmidt et al.
GUT (2010)
Unexpected Role for the Immunoproteasome Subunit LMP2 in Antiviral Humoral and Innate Immune Responses
Scott E. Hensley et al.
JOURNAL OF IMMUNOLOGY (2010)
Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome
Michael Basler et al.
JOURNAL OF IMMUNOLOGY (2010)
Neuroinflammatory processes in Alzheimer's disease
Michael T. Heneka et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Deletion of CD14 Attenuates Alzheimer's Disease Pathology by Influencing the Brain's Inflammatory Milieu
Erin G. Reed-Geaghan et al.
JOURNAL OF NEUROSCIENCE (2010)
Microglia in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2010)
Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population
Michele Mishto et al.
PLOS ONE (2010)
Proteasomes in immune cells: more than peptide producers?
Marcus Groettrup et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
Francesco Parlati et al.
BLOOD (2009)
Amyloid Deposition and Inflammation in APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
Lingfei Ruan et al.
CURRENT ALZHEIMER RESEARCH (2009)
The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide
David Schubert et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Intermediate filament transcription in astrocytes is repressed by proteasome inhibition
Jinte Middeldorp et al.
FASEB JOURNAL (2009)
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Erin G. Reed-Geaghan et al.
JOURNAL OF NEUROSCIENCE (2009)
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis
Tony Muchamuel et al.
NATURE MEDICINE (2009)
Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels
Mario Delgado et al.
GLIA (2008)
Immunoproteasome responds to injury in the retina and brain
Deborah A. Ferrington et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease
Karine L. Richard et al.
JOURNAL OF NEUROSCIENCE (2008)
Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice
Suzanne E. Hickman et al.
JOURNAL OF NEUROSCIENCE (2008)
Aβ inhibits the proteasome and enhances amyloid and tau accumulation
Bertrand P. Tseng et al.
NEUROBIOLOGY OF AGING (2008)
Aβ1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner
Sidhartha M. Chafekar et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Profiling proteasome activity in tissue with fluorescent probes
Celia R. Berkers et al.
MOLECULAR PHARMACEUTICS (2007)
β-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system
CG Almeida et al.
JOURNAL OF NEUROSCIENCE (2006)
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains
M Mishto et al.
NEUROBIOLOGY OF AGING (2006)
Amyloid peptide attenuates the proteasome activity in neuronal cells
S Oh et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2005)
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Y Liu et al.
BRAIN (2005)
CD14 is required for MyD88-independent LPS signaling
ZF Jiang et al.
NATURE IMMUNOLOGY (2005)
APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1
JL Jankowsky et al.
NEUROBIOLOGY OF AGING (2004)
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system
FMS de Vrij et al.
PROGRESS IN NEUROBIOLOGY (2004)
Protein degradation and protection against misfolded or damaged proteins
AL Goldberg
NATURE (2003)
A transgenic mouse model of the ubiquitin/proteasome system
K Lindsten et al.
NATURE BIOTECHNOLOGY (2003)
Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates
KJ Rodgers et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease
S Keck et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
G DiCarlo et al.
NEUROBIOLOGY OF AGING (2001)
Impaired proteasome function in Alzheimer's disease
JN Keller et al.
JOURNAL OF NEUROCHEMISTRY (2000)